Catalyst Wire Dossier Catalyst Wire Dossier

pirenzepine

pirenzepine · WinSanTor, Inc
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for pirenzepine, covering 2022-12-16 to 2023-12-04. Get the full timeline:

Most recent: Clinical Trial Update: A 16-Week Study of Pirenzepine or Placebo to Treat HIV-Associated Distal Sensory Polyneuropathy in Patients With HIV [Phase 2]

See pricing